Investor News Archives - Page 5 of 5

Inify Laboratories – now listed on Euronext Growth in Oslo under the INIFY ticker

Investor News 2022-06-20

“Today I’m truly thrilled to announce that Inify Laboratories is admitted to trading on Euronext Growth Oslo, less than 5 months after we became independent. With solid funding of NOK […]

Inify Laboratories – Decision on admission to trading – Euronext Growth Oslo

Investor News 2022-06-16

Stockholm, June 16, 2022 Oslo Børs has decided to admit Inify Laboratories AB to trading. It is stipulated that the company prior to the first day of trading must satisfy […]

Inify Laboratories – Extended subscription period

Investor News, News 2022-05-30

STOCKHOLM – May 30th, 2022 Inify Laboratories AB has decided to extend the Subscription Period in the ongoing Subsequent Offering to 3 June 2022 at 16:30 hours (CEST). As a […]

Inify Laboratories – extra bolagsstämma 2022-05-09

Investor News, News 2022-05-09

STOCKHOLM – 9 maj 2022 Inify Laboratories har hållit en extra bolagsstämma den 9 maj 2022. Bifogat finns en sammanfattning av de beslut som fattades vid den extra bolagsstämman. Vänligen […]

Inify Laboratories – kallelse till extra bolagsstämma

Investor News, News, Uncategorized 2022-04-11

STOCKHOLM – 11 april 2022 Inify Laboratories bjuder härmed in sina aktieägare till en extra bolagsstämma den 9 maj 2022. Bifogat finns kallelse inklusive dagordning och information om hur man […]

Inify Laboratories AB becomes an independent company

Home, Investor News, News 2021-12-10

STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved […]

ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service

Home, Investor News, News 2021-11-15

ContextVision today announces that the Board of Directors of ContextVision has decided to make a strategic shift and focus its pathology business unit entirely on the establishment of an AI based pathology lab service.

Aiming to build the company’s first modern pathology lab

Financial reports, Home, Investor News, News 2021-10-21

ContextVision has decided to build its first fully digital pathology laboratory – thus confirming its strong dedication to advancing digitalization within pathology, for the best of both patients and the medical profession.

Inify Laboratories – now listed on Euronext Growth in Oslo under the INIFY ticker

Inify Laboratories – Decision on admission to trading – Euronext Growth Oslo

Inify Laboratories – Extended subscription period

Inify Laboratories – extra bolagsstämma 2022-05-09

Inify Laboratories – kallelse till extra bolagsstämma

Inify Laboratories AB becomes an independent company

ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service

Aiming to build the company’s first modern pathology lab

Our services

Inify Laboratories

For Investors

Contact us

Social media